Canaccord Genuity Downgrades Stryker to Hold, Lowers Price Target to $300
Canaccord Genuity analyst Kyle Rose downgrades Stryker (NYSE:SYK) from Buy to Hold and lowers the price target from $385 to $300.
Share
Why It Matters
An expert analyst became less excited about Stryker stock and lowered their price goal. This hints the company might face some bumps ahead, so watch for updates.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.